Xenon Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
Tuesday, April 18, 2023 1 min read
Key Takeaway: BURNABY, British Columbia, April 18, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 22nd Annual Needham Virtual Healthcare Conference taking place April 17-20,
Market Sentiment Analysis
POSITIVE FACTORS
Xenon Pharmaceuticals will showcase its innovations at a prominent healthcare conference.
The presentation can enhance visibility and interest in its novel therapeutics.
The company's focus on neurological disorders addresses significant unmet medical needs.
Full Press Release Details
BURNABY, British Columbia, April 18, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 22nd Annual Needham Virtual Healthcare Conference taking place April 17-20, 2023.
Company Fireside Chat Presentation Details:
Date:
Thursday, April 20, 2023
Time:
2:15 pm Eastern Time (11:15 am Pacific Time)
Presenters:
Ian Mortimer, President and CEO
Sherry Aulin, CFO
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.